The vitamin D testing market is expected to cross ~USD 963.6 million by 2027 at a CAGR of ~6.1%. Absorption of calcium in the metabolic system is supported by vitamin D. It helps in regulating levels of calcium and phosphate in the blood. Moreover, a normal level of vitamin in the human body assists in bone mineralization to avoid conditions such as involuntary contraction of muscles. Additionally, pregnant women prone to vitamin D deficiency lead to conditions such as diabetes and preterm birth.
The growingnumber of patients suffering from vitamin D deficiency is boosting the demand for vitamin D testing products and thereby driving the growth of the vitamin D testing market. Moreover, an increasing number of awareness campaigns are anticipated to increase the demand for vitamin D testing products and services. For example, DSM India, a Koninklijke DSM N.V. (Netherlands) subsidiary, launched ‘Boost your ImmuniD’ campaign in India;addressing 80% of Indians with insufficient levels of Vitamin D. A huge burden of vitamin D deficiency globally coupled with rising awareness towards condition is expected to increase the vitamin D testing market size during the forecast period.
Vitamin D does not prevent a patient from contracting the COVID-19 infection, but it boostsimmunity. The rising prevalence of COVID-19 is projected to influence market growth over the forecast period. Pharmaceutical companies are currently working on understanding the association of levels of Vitamin D in blood with the severity of COVID-19 outcomes. Moreover, rising awareness of the importance of immunity required to fight infections has increased testing frequency.The work from home regulations in various countries is expected to increase the number of individuals unable to access sunlight for a sufficient amount of time. A recent Ipsos survey in collaboration with World Economic Forumpublished in July 2021 found 23% of employed adults working from home. More than one-third of employees surveyed in Peru, Singapore, India, and Argentina worked from home more frequently than traveling to offices.Thus, the COVID-19 pandemic is expected to be responsible for more employees working from home,resulting in limited sunlight exposure and thereby increasing chances of vitamin D deficiency.
There has been a high demand for vitamin D testing, and clinical studies are currently focused on assessing vitamin D levels in plasma or blood. These studies correlate vitamin D levels withthe severity of rickets, osteomalacia, COVID-19, obesity, and other conditions such as chronic inflammation. Moreover, there is a rising awareness about vitamin deficiency in developing countries, providing an impetus for increased clinical trials.Many recent observational studies conducted between 2020 and 2021 have found adequate vitamin D levels in the blood to reduce the severity and susceptibility of COVID-19 infection.
The high prevalence of vitamin D deficiency is responsible forthe burden of associated diseases such as rickets and osteomalacia.A large number of patients are globally suffering from diseases related to metabolism, bone health, and chronic kidney diseases. The diagnosis of such diseases needs timely evaluation of vitamin D levels. On the contrary, the reimbursement scenario is not favorable to address the large number of patients suffering from various associated conditions.The CPT Codes 82306 and 82652 for vitamin D testing are available for reimbursement in the US. However, in developing regions where a large population is affected by low levels of vitamin D, healthcare spending is not enough to address reimbursement concerns.
The large number of patients suffering from vitamin D deficiency globally is expected to increase the lucrativeness of the vitamin D testing market. Moreover, the manufacturers of various assays and kits can collaborate with research institutes to develop new products. Similarly, the diagnostic laboratories can capitalize on this opportunity to enter a long-term contract for population-based studies. Additionally, the supply of reagents, kits, and equipment necessary for vitamin D testing at an affordable price in developing regions can be a favorable strategy for players focused on geographic expansion.
The vitamin D testing market is growing steadily due to the rising number of research studies and increasing awareness related to low levels of vitamin D. The value chain analysis of the vitamin D testing market comprises four major components starting with the R&D and designing, followed by manufacturing the products, distribution & sales, and ends with post-sales services.
R&D and designing start with conceptualizing, followed by design, development, and testing. After the product designs are final, the manufacturing of the product starts. The sourcing of raw material is the initial phase in the manufacturing of the products. Outsourcing eliminates manufacturing process activities of some parts and helps to improve the efficiency of the process. Then comes distribution and sales, which is essential for any industry. Here, awareness about the products is spread across the market to get interested customers for the product. In post-sales services, customer feedback is taken into consideration to improve upon their existing product portfolio.
By Test Type
Vitamin D is converted enzymatically in the kidney to 1,25-dihydroxyvitamin D, the active form of vitamin D, abbreviated as 1,25(OH)2D. The concentration of 25(OH)D is almost 1000-fold that of 1,25(OH)2D and the half-life of 25(OH)D is much longer; this implies that its concentration is more stable. A much smaller percentage of 1, 25-dihydroxy vitamin D deficiency exists; mostly, in patients with renal disease and a history of organ transplant.
Vitamin D testing is important in understanding the prognosis of conditions in patients suffering from rickets and osteomalacia. Moreover, the signs and symptoms of poor bone health, diabetes, and chronic metabolic diseases,among other diseases in patients, increases the need for vitamin D testing. Similarly, the epidemiology studies conducted by various health departments require clinical testing.
The rise in R&D funding for research labs and universitiesis increasingthe number of researchers studying nutritional intake vis-à-vis rare diseases. These institutions are continuously involved in research activity to find a link between vitamin D levels and diseases.Some of the indications involving utilization of vitamin D testing include atopic dermatitis, inflammation, chronic obstructive pulmonary diseases, and rheumatic diseases. Moreover, clinical trials related to COVID-19 are assessing vitamin D levels through testing, thereby driving the growth of the market.
By End User
Laboratory tests and diagnostic procedures are used to check the normal health of a person.Diagnostic laboratories mostly employ 25-hydroxy vitamin D blood tests. Anemia, infection, and many other disorders are related to levels of vitamin D. Laboratory tests are important to understand pathophysiologic alterations.
Hospitals and clinics are prime centers for addressing abnormal health conditions and receiving treatment. The high prevalence of vitamin D deficiency globally is expected to drive the growth of this segment. Moreover, orthopedic hospitals need vitamin D levels tested for understanding the normal working of bones. Similarly, nutritionists need a complete profile of nutrients to advise and consult patients regarding diet.
There has been an increasing number of patients in need of at-home testing. The growing trend of the utility of at-home testing kits and increasing e-commerce portal delivering products are expected to fuel the growth of this segment. The manufacturers providing at-home vitamin D test kits include Everly Well, Inc. (US), and myLAB Box, Inc. (US).
The North American market accounted for the largest share in 2020,owing to the well-established healthcare system,the high adoption rateofmedical screening, and a highlevel of awareness regarding testing.Furthermore, the presence of major market players in this region and their contribution through mergers,acquisitions,and product launchesalso booststhe market growth.
The European vitamin D testing market is driven by the rising R&D expenditure by government institutes andan increasing number of clinical trials related to vitamin D testing. The presence of key market players also playsa significant role in contributing to market growth. Moreover, the increasing geriatric population suffering from orthopedic disorders drives the growth of the vitamin D testing market in the region.
The vitamin D testing marketin the region is expected to be the fastest-growing due to the increasing demand for testingand growing awareness among healthcare professionals in the region. In addition, factors such as the increasing number of awareness campaigns, government support for research studies,and significant investments by key market players also support the growth of this market.
Rising per capita expenditure of the healthcare sector and increasinginvestment by global nonprofit organizations are major factors contributing to the growth of the vitamin D testing market in this region.Moreover, the increasing presence of key companies in the region further drives the market growth.
The vitamin D testing market is profitable, both for existing players as well as new entrants. A substantial level of rivalry is observed among the existing manufacturers in the market. Our analysis revealed that market players had adopted different strategies and innovative marketing strategies to expand their business and secure their position in the vitamin D testing market.
Everlywell, Inc.(US) offers access to laboratory testing for wellness monitoring, informational and educational use. EverlyWellhas modernized lab testing by bringing access to credible, validated laboratory tests that are initiated and collected at home. The company provides test kits forfood sensitivity, vitamin D, metabolism, and COVID-19, among others.
Many market players are dominating the vitamin D testing market. The prominent players are involved in strategic agreements, product launches, and joint ventures to sustain their market positions.
List of Key Companies Covered in this report:
The study covers the existing short-term and long-term market effects, as well as helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter’s Five Forces, Value Chain, and impact of COVID-19 on the market. Scope of the Report
The scope of the vitamin D testing market study includes a market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on test type, application,end user,and region.
Vitamin D Testing Market, by Product
Vitamin D Testing Market, by Test
Vitamin D Testing Market, by Application
Vitamin D Testing Market, by End User
Vitamin D Testing Market, by Region
|Market Size||2027:~USD 963.6Million|
|Historical Data||2018 & 2019|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Test,Application, End User,and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, Rest of the World|
|Key Vendors||• bioMérieux SA (France) • Abbott Laboratories (US) • Beckman Coulter (US) • Thermo Fisher Scientific (US) • Mindray (China) • F. Hoffmann-La Roche Ltd (Switzerland) • Siemens Corporation (Germany) • Quest Diagnostics, Inc. (US) • DiaSorin S.p.A. (Italy) • Maccura (China) • Bio-Rad Laboratories (US) • Tosoh Bioscience (Japan) • Merck KGaA (Germany)|
|Key Market Opportunities||Collaboration with government agencies for diagnosis of deficiency|
|Key Market Drivers||• Increase in the number of clinical trials • High prevalence of vitamin D deficiency|